Is Fruquintinib a targeted drug?

Fruquintinib (Fruquintinib) is a targeted drug and a multi-target small molecule kinase inhibitor. It is mainly used to treat advanced gastric or colorectal cancer, especially in patients who have had limited response to traditional treatments. As a targeted drug, the therapeutic mechanism of fruquintinib mainly involves the intervention of specific growth factor receptors.

Specifically, fruquintinib mainly achieves therapeutic effects by inhibiting key targets such as vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR). These two receptors play an important role in the growth and spread of cancer cells. VEGFR is involved in the regulation of angiogenesis, while EGFR is related to the proliferation and survival of cancer cells.

By interfering with these signaling pathways, fruquintinib can precisely block the blood supply of tumor cells and inhibit their growth and spread. This highly specific mechanism of action is more precise than traditional chemotherapy drugs and can reduce the adverse effects on normal cells, thus reducing the incidence of side effects.

The advantage of targeted drugs lies in their more personalized treatment strategies, which can more accurately target the specific biological characteristics of cancer cells and improve the therapeutic effect. Although fruquintinib may be associated with some side effects during treatment, such as fatigue, loss of appetite, hypertension, etc., its side effects are usually more controllable and mild compared to traditional chemotherapy drugs with greater systemic toxicity.

Overall, fruquintinib, as a targeted drug, represents a step towards more precise and effective cancer treatment, providing patients with a more promising treatment option.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.